Material
Synthetic cyclic peptide analogue

Prepared for controlled laboratory evaluation of melanocortin-related signaling pathways.
* Vial labels may use shortened names to keep the label legible. The full material and composition are stated in this profile.
Synthetic cyclic peptide analogue
Single peptide material.
Melanocortin-pathway research.
Melanotan II draws attention for its broad melanocortin-receptor activity, linking pigmentation biology with centrally mediated physiological-response research.
Melanocortin signaling and pigmentation
Sexual-response, appetite, and autonomic pathways
A source-led view of the findings reported to date, the maturity of the evidence, and the limits that matter when interpreting it.
Small early human studies reported increased pigmentation and erectile responses. Nausea, yawning, stretching, appetite reduction, fatigue, and prolonged erections were among the reported observations.
Human evidence is old, small, and exploratory. These studies do not establish a general benefit-risk profile, consumer use, or equivalence between research material and the material used in those trials.
This summary describes published research on the named material or its components. It does not establish safety, efficacy, equivalence, or suitability of this Veyvanta research product for human use.
Convert a declared vial amount and diluent volume into nominal concentration, liquid volume, and the equivalent position on a U-100 scale.
Enter a positive diluent volume and target amount to calculate.
This tool performs unit conversion only. It does not recommend an amount, frequency, route, diluent, handling method, or human use. Results assume ideal mixing and a U-100 scale of 100 units per mL; validated laboratory procedures and material-specific compatibility take priority.
This is the evergreen product profile. Enter the code from a physical vial to display its specific record.
Verify this vialThis QR code opens the current product profile with its associated vial record.